• Je něco špatně v tomto záznamu ?

Genetic determination of plasma lipids and insulin in the Czech population

JA. Hubacek, DM. Waterworth, R. Poledne, J. Pitha, Z. Skodová, SE. Humphries, PJ. Talmud,

. 2001 ; 34 (2) : 113-118. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20013976

OBJECTIVES: To evaluate the association between plasma lipids and insulin and variation in the genes for apolipoproteins (APO) E (CfoI), B (insertion/deletion), C1 (HpaI), and C3 (C-482T, C3238G) in a population-based Czech Slavonic study. DESIGN AND METHODS: In 131 men and 154 women, polymorphisms were investigated using PCR. In the same subjects plasma lipid levels and insulin were measured. RESULTS: In the women, carriers of the e4 allele had higher apoB (p = 0.03) and triglyceride (p = 0.03) compared to e3 homozygotes, whereas in the men, the effect of the e4 allele was seen on total cholesterol (p = 0.02), LDL cholesterol (p = 0.003) and apoB (p = 0.001). Compared with SP27 (insertion) homozygotes of the APOB polymorphism, women SP24 (deletion) homozygotes had higher levels of total (p = 0.003) and LDL cholesterol (p = 0.007) and apoB (p = 0.05). No significant effect was seen in the men. Women homozygous for the APOC3 -482T allele had higher insulin levels than -482C homozygotes (p = 0.03). Men homozygous for APOC3 -482T allele have the highest plasma triglyceride level (p = 0.02). The APOC1 polymorphism exhibited no significant effect on any of the parameters studied. CONCLUSIONS: In this sample, variation at the APOE, APOB and APOC3 genes play a role in determining plasma levels of insulin and lipids, and emphasize the importance of gender-associated effects in the genetic determinations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20013976
003      
CZ-PrNML
005      
20200915104402.0
007      
ta
008      
200911s2001 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/s0009-9120(01)00184-9 $2 doi
035    __
$a (PubMed)11311220
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hubacek, J A $u Cardiovascular Genetic, Rayne Institute, Department of Medicine, Royal Free and University College London Medical School, WC1E 6JJ, London, England. jaroslav.hubacek@medicon.cz
245    10
$a Genetic determination of plasma lipids and insulin in the Czech population / $c JA. Hubacek, DM. Waterworth, R. Poledne, J. Pitha, Z. Skodová, SE. Humphries, PJ. Talmud,
520    9_
$a OBJECTIVES: To evaluate the association between plasma lipids and insulin and variation in the genes for apolipoproteins (APO) E (CfoI), B (insertion/deletion), C1 (HpaI), and C3 (C-482T, C3238G) in a population-based Czech Slavonic study. DESIGN AND METHODS: In 131 men and 154 women, polymorphisms were investigated using PCR. In the same subjects plasma lipid levels and insulin were measured. RESULTS: In the women, carriers of the e4 allele had higher apoB (p = 0.03) and triglyceride (p = 0.03) compared to e3 homozygotes, whereas in the men, the effect of the e4 allele was seen on total cholesterol (p = 0.02), LDL cholesterol (p = 0.003) and apoB (p = 0.001). Compared with SP27 (insertion) homozygotes of the APOB polymorphism, women SP24 (deletion) homozygotes had higher levels of total (p = 0.003) and LDL cholesterol (p = 0.007) and apoB (p = 0.05). No significant effect was seen in the men. Women homozygous for the APOC3 -482T allele had higher insulin levels than -482C homozygotes (p = 0.03). Men homozygous for APOC3 -482T allele have the highest plasma triglyceride level (p = 0.02). The APOC1 polymorphism exhibited no significant effect on any of the parameters studied. CONCLUSIONS: In this sample, variation at the APOE, APOB and APOC3 genes play a role in determining plasma levels of insulin and lipids, and emphasize the importance of gender-associated effects in the genetic determinations.
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a apolipoprotein C-I $7 D053302
650    _2
$a apolipoprotein C-III $7 D053305
650    _2
$a apolipoproteiny B $x genetika $7 D001055
650    _2
$a apolipoproteiny C $x genetika $7 D001056
650    _2
$a apolipoproteiny E $x genetika $7 D001057
650    _2
$a cholesterol $x krev $7 D002784
650    _2
$a HDL-cholesterol $x krev $7 D008076
650    _2
$a LDL-cholesterol $x krev $7 D008078
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická variace $7 D014644
650    _2
$a genotyp $7 D005838
650    _2
$a homozygot $7 D006720
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x krev $7 D007328
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a sexuální faktory $7 D012737
650    _2
$a triglyceridy $x krev $7 D014280
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Waterworth, D M
700    1_
$a Poledne, R
700    1_
$a Pitha, J
700    1_
$a Skodová, Z
700    1_
$a Humphries, S E
700    1_
$a Talmud, P J
773    0_
$w MED00001119 $t Clinical biochemistry $x 0009-9120 $g Roč. 34, č. 2 (2001), s. 113-118
856    41
$u https://pubmed.ncbi.nlm.nih.gov/11311220 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200911 $b ABA008
991    __
$a 20200915104358 $b ABA008
999    __
$a ok $b bmc $g 1563414 $s 1104133
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2001 $b 34 $c 2 $d 113-118 $e - $i 0009-9120 $m Clinical biochemistry $n Clin Biochem $x MED00001119
LZP    __
$a Pubmed-20200911

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...